WebFeb 1, 2024 · AviadoBio, a pioneering, pre-clinical stage gene therapy company focused on developing and delivering transformative medicines for people with neurodegenerative disorders, today announced the appointment of Jeff Goater as Chair of the AviadoBio Board of Directors, effective immediately.Mr. Goater brings more than 20 years of biotech … WebFeb 3, 2024 · AviadoBio, a pre-clinical stage platform company with operations in the UK and the US and backed by NEA, F-Prime and J&J Innovation and focused on developing and delivering transformative gene therapies for people with neurodegenerative disorders, has appointed Jeff Goater as Chair of its Board of Directors. Jeff brings more than 20 years of …
Jeff Goater - Board Member - Remix Therapeutics LinkedIn
WebJeff Goater is a Venture Partner at The Column Group. Previously, he served as Chief Executive Officer of Surface Oncology from February 2024 to March 2024. Prior to … WebFeb 1, 2024 · Mr. Goater is an esteemed Venture Partner at The Column Group and Interim CEO of Atavistik Bio. His impressive career includes a transformative tenure as CEO of Surface Oncology, where he fostered a highly-praised culture, drove four programs into clinical development, and took the company public, alongside securing several strategic ... buffalo exchange u district
The Column Group on LinkedIn: Mr. Jeff Goater joins The Column Group …
WebJeff Goater has served as a member of our board of directors since September 2024. Jeff Goater is a Venture Partner at The Column Group. Previously, he served as Chief Executive Officer of Surface Oncology. During his tenure at Surface, the company fostered an award-winning culture, advanced four programs into clinical development, completed its initial … WebFeb 3, 2024 · Jeff brings more than 20 years of biotech and Wall Street experience to this appointment. Currently, Jeff is a Venture Partner at The Column Group and interim CEO of Atavistik Bio. Previous roles include CEO of Surface Oncology and Managing Director at Evercore Partners. WebThe Column Group announces the promotion of Dr. Millie Ray from Principal to Partner. Dr. Ray has been with TCG since 2024. Previous Mr. Jeff Goater joins The Column Group as … buffalo exchange uptown